Get started
Author

Jill F. Blim

Observed names: Blim, Jill F., Jill Blim
OpenAlex ID: A5008042781
Economic Value of Anti–Vascular Endothelial Growth Factor Treatment for Patients With Wet Age-Related Macular Degeneration in the United States
2019 · Karen Mulligan, Seth A. Seabury, et al. · JAMA Ophthalmology · 50
PDF
Evaluation of Clinical Questions and Patient-Important Outcomes Associated With the Treatment of Age-Related Macular Degeneration
2018 · Kristina B. Lindsley, Susan Hutfless, et al. · JAMA Ophthalmology · 18
PDF
Opportunity Cost of Retinal Detachment Surgery vs Office-Based Patient Care
2022 · Ella H. Leung, Henry A. Leder, et al. · Journal of VitreoRetinal Diseases · 12
Trends in Medicare Reimbursement for Common Vitreoretinal Procedures: 2011 to 2020
2022 · Nicolaas P. DeRuyter, Shriji Patel, et al. · Ophthalmology · 12
The Broader Economic Value of Treatment for Diabetic Macular Edema
2023 · Karen Mulligan, Jaehong Kim, et al. · Diabetes Care · 11
Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices
2024 · Sabin Dang, D. Wilkin Parke, et al. · JAMA Ophthalmology · 6
Opportunity Cost of Vitreoretinal Surgeries
2023 · Ella H. Leung, Shriji Patel, et al. · Journal of VitreoRetinal Diseases · 3
PDF
The Impact of COVID-19 on US and International Retina Specialists, Their Practices, and Their Patients
2021 · Paul Hahn, Jill F. Blim, et al. · Journal of VitreoRetinal Diseases · 3
PDF
Comparison of Medicaid Vs Medicare Reimbursement Rates for Vitreoretinal Surgeries in the United States
2026 · Ella H. Leung, Ghassan Ghorayeb, et al. · Journal of VitreoRetinal Diseases · 2
Cost-Effectiveness of Treatments for Diabetic Macular Edema: Simulated Bevacizumab-First Step Therapy Versus Real-World Practice
2025 · Ella H. Leung, Dilraj S. Grewal, et al. · Journal of VitreoRetinal Diseases · 2
Bevacizumab First in DRCR Protocol AC vs Real-World Physician Treatment Choice for Diabetic Macular Edema: Two-Year Cost Analysis
2024 · Dilraj S. Grewal, Ella Leung, et al. · Journal of VitreoRetinal Diseases · 2
PDF
Operating Room Access: Survey of the American Society of Retina Specialists
2026 · Ella H. Leung, Jill Blim, et al. · Journal of VitreoRetinal Diseases · 1
Economic Impact of Antivascular Endothelial Growth Factor Prior Authorization Process From a Large Electronic Database
2025 · Ella H. Leung, Saira Khanna, et al. · Journal of VitreoRetinal Diseases · 1
Supply Chain Volatility of Repackaged Intravitreal Bevacizumab: A Survey of the American Society of Retina Specialists
2025 · Hasenin Al-khersan, Miguel Busquets, et al. · Journal of VitreoRetinal Diseases · 1
From the Editors
2021 · Donald J. D’Amico, Timothy G. Murray, et al. · Journal of VitreoRetinal Diseases · 1
Real-World Versus Centers for Medicare and Medicaid Services Estimates of Pediatric Retinal Detachment Repair Times
2026 · Ella H. Leung, Hong-Uyen Hua, et al. · Journal of VitreoRetinal Diseases
OCT as a Dynamic Biomarker in Retinal Disease Management: Evidence, Decision Strategies, and Clinical Guidance for OCT Decision-Point Use
2026 · Ghassan Ghorayeb, Mohsin H. Ali, et al. · Journal of VitreoRetinal Diseases
A Comparative Time-Based Profit Analysis of Retinal and Cataract Surgery in Ambulatory Surgery Centers
2026 · Miguel A. Busquets, Hasenin Al-khersan, et al. · Journal of VitreoRetinal Diseases
Underfunding of a Patient Copay Assistance Program and the Impact on Retinal Disease Care: Survey of ASRS Members
2026 · Ella H. Leung, Ghassan Ghorayeb, et al. · Journal of VitreoRetinal Diseases
The Broader Economic Value of Treatment for Diabetic Macular Edema
2023 · Karen Mulligan, Jaehong Kim, et al.
The Broader Economic Value of Treatment for Diabetic Macular Edema
2023 · Karen Mulligan, Jaehong Kim, et al.
PDF
Works count: 28
Citation count: 125
H-index: 6
I10-index: 5
Year
Topic
Type